Henan Taloph Pharmaceutical Stock Co.,Ltd (600222.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2214
First IPO Date
November 05, 1999
| Name | Title | Pay | Year Born |
| Fengshan Su | Executive Vice General Manager | 0 | 1977 |
| Hailin Zhao | CFO & Deputy GM | 0 | 1975 |
| Jingliang Li | GM & Vice Chairman | 0 | 1969 |
| Lizhuang Zhang | Deputy General Manager | 0 | 1966 |
| Feng Yun Chen | Accounting Supervisor & Employee Representative Director | 0 | N/A |
| Nianyun Li | Deputy GM & Secretary | 0 | 1991 |
Operating from Zhengzhou, China, Henan Taloph Pharmaceutical Stock Co., Ltd. specializes in the research, development, production, and sale of a wide array of Chinese and Western medicines across the nation. The company's product line encompasses various forms, such as oral liquids, tablets, capsules, and injectable fluids. Notable products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, and pazufloxacin mesylate sodium chloride injections, alongside a selection of other infusion products. Taloph Pharmaceutical serves a diverse client base, including hospitals, pharmacies, and direct consumers. It was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd.